Chancellor Reeves Aims for Specific Measures on Living Costs in Upcoming Budget

Treasury head Rachel Reeves has stated she is preparing "focused action to deal with cost of living challenges" in next month's Budget.

Speaking to media outlets, she noted that curbing price rises is a joint responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven developed nations this calendar year and the following year.

Potential Energy Bill Measures

It is understood the administration could take action to bring down energy bills, for example by slashing the current 5% rate of VAT applied on energy.

An additional possibility is to reduce some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will receive the latest assessment from the official forecaster, the OBR, on Monday, which will show how much scope there is for such measures.

The expectation from the majority of experts is that the Chancellor will have to introduce tax rises or budget cuts in order to adhere to her voluntary borrowing rules.

Previously on Thursday, analysis suggested there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of forecasts.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the sources of price increases," Reeves stated to the BBC in Washington, at the annual meetings of the IMF and World Bank.

Tax Pledges and International Concerns

While much of the attention has been on likely tax increases, the Treasury chief said the most recent information from the OBR had not changed her pledge to election pledges not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing geopolitical and commercial issues for the fiscal tax moves, probably to be directed on those "wealthiest."

International Economic Tensions

Referring to worries about the UK's trade ties with the Asian nation she said: "The UK's security interests invariably take priority."

Last week's statement by Chinese authorities to increase export controls on rare earths and other resources that are key for high-technology manufacturing led US President Donald Trump to suggest an extra 100% tariff on goods from the Asian country, increasing the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary called China's decision "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the American proposal to participate in its conflict with China, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Chinese government "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and creates further obstacles."

"In my view there are areas where we need to confront Chinese policies, but there are also valuable prospects to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that balance appropriate."

The Treasury chief also stated she was working with international partners "regarding our own critical minerals approach, so that we are less reliant."

NHS Medicine Costs and Investment

The Chancellor also admitted that the price the National Health Service pays for medicines could go up as a consequence of ongoing negotiations with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest drug companies have said recently that they are either pausing or scrapping projects in the United Kingdom, with some blaming the low prices they are receiving.

Last month, the Science Minister said the price the health service spends on drugs would have to increase to halt companies and drug research funding leaving the United Kingdom.

Reeves informed the BBC: "It has been observed because of the payment system, that clinical trials, new drugs have not been available in the UK in the manner that they are in other European countries."

"The objective is to ensure that individuals getting care from the National Health Service are can receive the best life-saving medicines in the world. And so we are examining all of that, and... seeking to secure more funding into the UK."